![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » ProstaLund Enters U.S. Market With Opening of L.A. Office
ProstaLund Enters U.S. Market With Opening of L.A. Office
May 5, 2005
ProstaLund, a Swedish developer and manufacturer of medical devices, announced the opening of ProstaLund, a wholly owned subsidiary based in Los Angeles, Calif. ProstaLund is the developer of CoreTherm, a unique medical device that utilizes minimally invasive, microwave thermotherapy to treat an enlarged prostate (BHP -- benign prostatic hyperplasia), which affects millions of men in the U.S.
ArriveNet (http://press.arrivenet.com/hea/article.php/632098.html)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct